HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J L Holley Selected Research

Hepatitis B

8/2000The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J L Holley Research Topics

Disease

2Chronic Kidney Failure (Chronic Renal Failure)
05/2001 - 08/2000
1Heart Arrest (Cardiac Arrest)
10/2001
1Dyslipidemias (Dyslipidemia)
05/2001
1Cardiovascular Diseases (Cardiovascular Disease)
05/2001
1Osteoporosis
05/2001
1Hepatitis B
08/2000

Drug/Important Bio-Agent (IBA)

1Hormones (Hormone)IBA
05/2001
1AntigensIBA
08/2000
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2000
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
08/2000

Therapy/Procedure

1Cardiopulmonary Resuscitation (CPR)
10/2001
1Therapeutics
05/2001
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
05/2001
1Renal Dialysis (Hemodialysis)
08/2000
1Injections
08/2000